Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same authorSame journal

AI-assisted image analysis of tumor-infiltrating lymphocytes as a prognostic marker in chemotherapy-naïve luminal breast cancer.

NPJ breast cancer·2026
Same author

Development and Validation of an Algorithm to Achieve Complete Registration of Danish Patients with Carcinoma In Situ of the Breast, 2008-2023.

Clinical epidemiology·2026
Same author

Statin use and risk of contralateral breast cancer: an updated cohort study with landmark analysis.

European journal of epidemiology·2026
Same author

Metabolic, enterohepatic and gut microbial effects of atorvastatin in healthy men.

Endocrine connections·2026
Same author

17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark.

Breast cancer research : BCR·2025
Same author

Validation of a deep learning-based AI model for breast cancer risk stratification in postmenopausal ER+/HER2-breast cancer patients.

Breast (Edinburgh, Scotland)·2025

相关实验视频

Updated: Sep 9, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.1K

用定量转录组学增强低HER2乳腺癌的检测

Maria-Anna Misiakou1, Maj-Britt Jensen2, Maj-Lis Talman3

  • 1Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

NPJ breast cancer
|September 1, 2025
PubMed
概括

转录组学准确地识别了乳腺癌中的HER2表达,即使在标准IHC呈阴性的情况下. 这种方法有助于选择患者接受针对HER2的治疗,改善治疗结果.

更多相关视频

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.7K
Evaluation of Lung Metastasis in Mouse Mammary Tumor Models by Quantitative Real-time PCR
08:56

Evaluation of Lung Metastasis in Mouse Mammary Tumor Models by Quantitative Real-time PCR

Published on: January 29, 2016

10.0K

相关实验视频

Last Updated: Sep 9, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.1K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.7K
Evaluation of Lung Metastasis in Mouse Mammary Tumor Models by Quantitative Real-time PCR
08:56

Evaluation of Lung Metastasis in Mouse Mammary Tumor Models by Quantitative Real-time PCR

Published on: January 29, 2016

10.0K

科学领域:

  • 癌症学
  • 分子生物学
  • 基因组学

背景情况:

  • 对于乳腺癌治疗决定来说,精确的皮肤生长因子受体2 (HER2) 评估至关重要.
  • 标准免疫组织化学 (IHC) 方法难以可靠地识别HER2的低表达,这是一个越来越重要的治疗领域.

研究的目的:

  • 评估转录组学在乳腺癌中敏感检测ERBB2 (HER2) mRNA表达的有用性.
  • 为了确定转录HER2检测是否可以改善患者对抗HER2疗法的分层,超出传统的IHC分类.

主要方法:

  • 对3182例乳腺瘤进行了ERBB2mRNA表达的转录组分析.
  • 用抗HER2疗法治疗的患者的转录组数据与IHC分类和病理完整反应率的相关性.

主要成果:

  • 在IHC 0 (HER2- 阴性) 的86%的瘤中发现了可检测的ERBB2mRNA.
  • 在接受抗HER2治疗的患者中,较高的ERBB2mRNA表达水平与病理完整反应率的增加相关.

结论:

  • 转录组学为检测HER2表达提供了一种敏感的方法,补充了乳腺癌的标准IHC.
  • 这种方法可以完善 HER2 向治疗的患者分层,从而最大限度地提高治疗效果.